Pure Global AI
ANVISA registration 10287411763Valid until Sep 15, 2035

IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL

ANVISA Registration Number: 10287411763ROCHE DIAGNÓSTICA BRASIL LTDAVENTANA MEDICAL SYSTEM, INCRisk Class III
Verified
Device names
Technical name
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
View exact technical-name matches →
PT: IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
Commercial name
INSM1 (SP493) Rabbit Monoclonal Primary Antibody
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10287411763
Process Number
25351092392202532
CNPJ
30280358000186
Company information
Registration Holder
ROCHE DIAGNÓSTICA BRASIL LTDA
Manufacturer
VENTANA MEDICAL SYSTEM, INC
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Sep 15, 2025
Validity
15/09/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411763 and manufactured by VENTANA MEDICAL SYSTEM, INC. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Sep 15, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.